News Releases :: Sutro Biopharma, Inc. (STRO)

Aug 13, 2018 8:00 am EDT

Sutro and The Leukemia & Lymphoma Society Partner on Lymphoma and Multiple Myeloma Treatment

Jul 26, 2018 10:45 am EDT

Sutro Biopharma Announces $85.4 Million Series E Round

Jul 24, 2018 8:00 am EDT

Sutro Biopharma Collaborates with Merck to Develop Therapeutics for Cancer and Autoimmune Disorders

Apr 26, 2018 8:00 am EDT

Sutro Initiates First Clinical Trial of CD74-Targeting ADC for Lymphoma & Multiple Myeloma Treatment; The First of a New Generation of Precisely Engineered ADCs

Apr 16, 2018 6:30 am EDT

Sutro ADC Effectively Targets Folate Receptor Alpha in Ovarian Cancer Preclinical Research

Dec 12, 2017 8:00 am EST

Sutro Antibody Effectively Targets CD74 in Lymphoma & Multiple Myeloma Preclinical Studies

Oct 11, 2017 8:00 am EDT

Sutro Marks Two Drug Development Milestones

Aug 10, 2017 8:00 am EDT

Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs

Jul 17, 2017 8:00 am EDT

New Evidence of Sutro ADC's Potency in Human Tumor Xenografts

Apr 27, 2017 8:00 am EDT

Sutro Appoints Lobacki as Director; Leonard, Krishnan & Levy as Advisors